Annual EBITDA
-$86.50 M
-$2.41 M-2.87%
December 31, 2023
Summary
- As of February 8, 2025, OMIC annual EBITDA is -$86.50 million, with the most recent change of -$2.41 million (-2.87%) on December 31, 2023.
- During the last 3 years, OMIC annual EBITDA has fallen by -$59.91 million (-225.32%).
- OMIC annual EBITDA is now -623.39% below its all-time high of -$11.96 million, reached on December 31, 2019.
Performance
OMIC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$14.82 M
+$4.37 M+22.77%
September 30, 2024
Summary
- As of February 8, 2025, OMIC quarterly EBITDA is -$14.82 million, with the most recent change of +$4.37 million (+22.77%) on September 30, 2024.
- Over the past year, OMIC quarterly EBITDA has increased by +$6.49 million (+30.46%).
- OMIC quarterly EBITDA is now -193.08% below its all-time high of -$5.06 million, reached on March 1, 2020.
Performance
OMIC Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$78.33 M
+$5.39 M+6.43%
September 30, 2024
Summary
- As of February 8, 2025, OMIC TTM EBITDA is -$78.33 million, with the most recent change of +$5.39 million (+6.43%) on September 30, 2024.
- Over the past year, OMIC TTM EBITDA has increased by +$8.16 million (+9.44%).
- OMIC TTM EBITDA is now -1449.29% below its all-time high of -$5.06 million, reached on March 1, 2020.
Performance
OMIC TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
OMIC EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.9% | +30.5% | +9.4% |
| 3 y3 years | -225.3% | +30.5% | +9.4% |
| 5 y5 years | -623.4% | +30.5% | +9.4% |
OMIC EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -2.9% | +10.6% | at high | +36.8% | at high | +19.1% |
| 5 y | 5-year | -623.4% | +10.6% | -193.1% | +59.9% | -1449.3% | +19.1% |
| alltime | all time | -623.4% | +10.6% | -193.1% | +59.9% | -1449.3% | +19.1% |
Singular Genomics Systems EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$14.82 M(-22.8%) | -$78.33 M(-6.4%) |
| Jun 2024 | - | -$19.19 M(-16.6%) | -$83.72 M(-4.8%) |
| Mar 2024 | - | -$23.02 M(+8.0%) | -$87.96 M(+1.7%) |
| Dec 2023 | -$86.50 M(+2.9%) | -$21.31 M(+5.5%) | -$86.50 M(+2.6%) |
| Sep 2023 | - | -$20.20 M(-13.7%) | -$84.33 M(-2.0%) |
| Jun 2023 | - | -$23.43 M(+8.7%) | -$86.03 M(+1.4%) |
| Mar 2023 | - | -$21.56 M(+12.6%) | -$84.88 M(+0.9%) |
| Dec 2022 | -$84.08 M | -$19.14 M(-12.7%) | -$84.08 M(-0.1%) |
| Sep 2022 | - | -$21.91 M(-1.6%) | -$84.15 M(+6.1%) |
| Jun 2022 | - | -$22.27 M(+7.3%) | -$79.31 M(-15.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$20.76 M(+8.1%) | -$94.03 M(-2.9%) |
| Dec 2021 | -$96.79 M(+264.0%) | -$19.20 M(+12.5%) | -$96.79 M(+13.8%) |
| Sep 2021 | - | -$17.07 M(-53.8%) | -$85.09 M(+12.6%) |
| Jun 2021 | - | -$36.99 M(+57.3%) | -$75.57 M(+67.7%) |
| Mar 2021 | - | -$23.52 M(+213.7%) | -$45.05 M(+69.5%) |
| Dec 2020 | -$26.59 M(+122.4%) | -$7.50 M(-0.8%) | -$26.59 M(+39.3%) |
| Sep 2020 | - | -$7.56 M(+16.8%) | -$19.09 M(+65.6%) |
| Jun 2020 | - | -$6.47 M(+28.0%) | -$11.53 M(+128.0%) |
| Mar 2020 | - | -$5.06 M | -$5.06 M |
| Dec 2019 | -$11.96 M | - | - |
FAQ
- What is Singular Genomics Systems annual EBITDA?
- What is the all time high annual EBITDA for Singular Genomics Systems?
- What is Singular Genomics Systems annual EBITDA year-on-year change?
- What is Singular Genomics Systems quarterly EBITDA?
- What is the all time high quarterly EBITDA for Singular Genomics Systems?
- What is Singular Genomics Systems quarterly EBITDA year-on-year change?
- What is Singular Genomics Systems TTM EBITDA?
- What is the all time high TTM EBITDA for Singular Genomics Systems?
- What is Singular Genomics Systems TTM EBITDA year-on-year change?
What is Singular Genomics Systems annual EBITDA?
The current annual EBITDA of OMIC is -$86.50 M
What is the all time high annual EBITDA for Singular Genomics Systems?
Singular Genomics Systems all-time high annual EBITDA is -$11.96 M
What is Singular Genomics Systems annual EBITDA year-on-year change?
Over the past year, OMIC annual EBITDA has changed by -$2.41 M (-2.87%)
What is Singular Genomics Systems quarterly EBITDA?
The current quarterly EBITDA of OMIC is -$14.82 M
What is the all time high quarterly EBITDA for Singular Genomics Systems?
Singular Genomics Systems all-time high quarterly EBITDA is -$5.06 M
What is Singular Genomics Systems quarterly EBITDA year-on-year change?
Over the past year, OMIC quarterly EBITDA has changed by +$6.49 M (+30.46%)
What is Singular Genomics Systems TTM EBITDA?
The current TTM EBITDA of OMIC is -$78.33 M
What is the all time high TTM EBITDA for Singular Genomics Systems?
Singular Genomics Systems all-time high TTM EBITDA is -$5.06 M
What is Singular Genomics Systems TTM EBITDA year-on-year change?
Over the past year, OMIC TTM EBITDA has changed by +$8.16 M (+9.44%)